Press release
myriamed has joined Science Exchange
myriamed has joined Science Exchange
Please visit our profile here: http://bit.ly/myriamed_Science_Exchange
About myriamed: myriamed has unique expertise in research and development of human induced pluripotent stem cells (iPSC), including genome edited lines, and in the controlling of their fate as to the differentiation into defined cellular lineages and tissues (published for example in Tiburcy et al. 2017 and Long et al. 2018). The myriamed product portfolio is constantly evolving and based on a comprehensive IP portfolio to offer its know-how and associated services in drug development.
About Science Exchange: Founded in 2011 in response to the global growth in R&D services, Science Exchange solves the challenges of outsourcing R&D by removing barriers in the outsourcing process – providing companies with instant access to a network of pre-qualified service providers, as well as contracting, project management and reporting tools. The Science Exchange platform increases scientists' access to innovation and improves productivity, freeing them up from the administrative tasks and delays associated with sourcing, establishing and managing service provider contracts. Additionally, the Science Exchange enterprise program enables organizations to consolidate R&D outsourcing spend into a single strategic relationship, driving efficiency and cost savings. Since 2011, Science Exchange has raised more than $70 million from Norwest Venture Partners, Maverick Ventures, Union Square Ventures, Collaborative Fund, Windham Ventures, OATV, the YC Continuity Fund, and others. Visit www.scienceexchange.com or connect via www.linkedin.com/company/science-exchange.
myriamed GmbH
Rudolf-Wissell-Str. 28a
37079 Göttingen
Tel.: +49 551 28878-170
Email: info@myriamed.com
Web: www.myriamed.com
myriamed – the drug development accelerator
Separating the pharmacological wheat from the chaff is the primary goal of myriamed. Our proprietary human cell and engineered tissue models allow for the simulation of health and disease in the dish. Our platform technologies find broad applications in early stages of drug discovery and refinement of the most promising therapeutic candidates.
The availability of human cell and tissue models is transforming preclinical drug development. Applications range from early stages of lead discovery to advanced individualized phenotypic screens to shape a promising therapeutic candidate. myriamed offers a broad portfolio of highly standardized services as well as custom-made solutions to accelerate drug development.
At myriamed we focus on heart and skeletal muscle as well as on neuronal organoids. Our myrCell and myrTissue platforms define wanted and unwanted drug effects in a unique human context. myrScreen combines our expertise in phenotypic drug screens and enables deep phenotyping of drug effects on healthy or diseased human heart and skeletal muscle as well as on neuronal organoids.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release myriamed has joined Science Exchange here
News-ID: 2257706 • Views: …
More Releases from myriamed GmbH
myriamed launches online shop
To deliver the best possible service to our customers, myriamed has launched its own online shop. The shop features various human iPSC derived cell types (myrCell) such as cardiomyocytes, skeletal muscle cells and stroma cells as well as various tissue types (myrTissue) such as cardiac tissue, fibrotic tissue or brain organoids. In addition, you can order our proprietary tissue culture plates (myrPlates) via the shop to cast and culture macroscale…
myriamed is a member of the international 4D Bioprinting network
myriamed has become a member of the ZIM innovation network 4D Bioprinting. The network, which is led by EurA AG supports concrete innovative products and new services in the field of bioprinting for applications in biology, pharmacy, and medicine. Thus, the network promotes the commercialization of the innovative technologies of the network partners by market-oriented R&D projects and establishment of new value chains for biopharmaceuticals and medicine.
Phase 1 of the…
myriamed is now a member of the Network for Pharma Solutions
We are proud to announce that myriamed is now a member of the Network for Pharma Solutions (NetPhaSol). NetPhaSol is a cooperation network focusing on drug discovery & development. It serves as a platform for research, development and marketing of new products, technologies and services in drug development.
About myriamed: myriamed has unique expertise in research and development of human induced pluripotent stem cells (iPSC), including genome edited lines, and in…
More Releases for Science
Jeremy McGilvrey Announces "Science Fiction Is Now Science Fact
Houston-Based CRO Agency Jeremy McGilvrey Announces "Science Fiction Is Now Science Fact"
Jeremy McGilvrey, a Houston-based digital marketing agency announces that what was once thought to be science fiction when it comes to AI in lead generation, marketing and digital presence has become science fact.
Jeremy McGilvrey agency believes the future isn't coming, it's here. Specifically, the digital marketing agency argues that advancements in AI and data science under the context of…
ORU Offers New Master’s Degrees in Computer Science and Data Science
Tulsa, OK – Oral Roberts University’s Department of Computing & Mathematics has introduced new master’s degrees in MSCS – Computer Science and MSCS – Data Science. Available to students on campus, the Master of Science in Computer Science (MSCS) has two concentrations to choose from – Computer Science and Data Science.
According to code.org, there are more than 389,000 computing jobs open nationwide, and less than 72,000 computer sciences students graduated…
SeeRRI meets Junge Uni Krems: science literacy and science education (SLSE)
The SLSE indicator in the MORRI framework (Strand, 2015) reflects the importance of societal aspects of science in science curricula for 15 to 18-year-old students. In order to create some impact on this indicator, the SeeRRI project is organizing educational activities related to entrepreneurship and the societal aspects of science and innovation in three territories.
The Research and Innovation Management GmbH and the University of Haifa prepared a first workshop…
Cell Science 2017
It takes us immense pleasure to announce the conference that “Annual Congress on Cell Science, Stem Cell Research & Regenerative Medicine” which is going to be held during November 29-30, 2017 at Atlanta, USA.
Cell Science 2017 conference will focus on the latest and exciting innovations in all areas of Cell Biologists and Stem Cell Researchers which offer a unique opportunity for investigators across the globe to meet, network, and perceive…
Cell Science 2017
Pulsus Group is an internationally renowned medical peer-review publisher and conferences organizer established in the year 1984 publishes and hosts the work of researchers in a manner that exemplifies the highest standards in research integrity.With a legacy of 30 years of excellence in Medical Publishing we are endorsed by various societies like International Academy of Cardiovascular Sciences, International Society of Addiction Medicine, European Biotechnology Thematic Network Association, World Federation of…
Bioelectronic Medicine: Science Fiction or Science Fact?
The resounding answer to the above question is, science fact! Bioelectronic Medicine is, and will continue to be, one of the fastest-growing industries, within the medical sector. BAC Medical Marketing has positioned itself perfectly to take full advantage of the rapid growth of Bioelectronic Medicine by offering a state-of-the-art device, and accompanying software, that has been used successfully by doctors on their patients throughout Europe and Asia for many years,…
